This list is based on the watchlists of people on Stock Events who follow 8N10.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Biosergen AB (publ), a biotech company, develops antifungal products. Its lead product is BSG005, an antifungal drug candidate for the treatment of invasive fungal infections in immunocompromised patients, including AIDS, cancer, and transplant recipients. The company was founded in 2004 and is based in Solna, Sweden.
The current price of 8N10.F is €0.86 EUR — it has decreased by -2.27% in the past 24 hours. Watch Biosergen AB stock price performance more closely on the chart.
What is Biosergen AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Biosergen AB stocks are traded under the ticker 8N10.F.
What is Biosergen AB market cap?▼
Today Biosergen AB has the market capitalization of 201.95M
When is the next Biosergen AB earnings date?▼
Biosergen AB is going to release the next earnings report on May 28, 2026.
What is Biosergen AB revenue for the last year?▼
Biosergen AB revenue for the last year amounts to 0 EUR.
What is Biosergen AB net income for the last year?▼
8N10.F net income for the last year is -3.35M EUR.
How many employees does Biosergen AB have?▼
As of May 02, 2026, the company has 1 employees.
In which sector is Biosergen AB located?▼
Biosergen AB operates in the Other sector.
When did Biosergen AB complete a stock split?▼
The last stock split for Biosergen AB was on December 01, 2025 with a ratio of 1:100.